Publication | Closed Access

Discontinuation of Infliximab in Patients With Ulcerative Colitis Is Associated With Increased Risk of Relapse: A Multinational Retrospective Cohort Study

InflammationAnti-inflammatoryClinical EpidemiologyGastroenterologyChronic InflammationIncreased RiskPublic HealthUlcerative ColitisMedicineInflammatory DiseaseEpidemiology